Cilostazol prevents foot ulcers in diabetic patients with peripheral vascular disease.


Diabetic patients are at high risk of foot ulcerations that may lead to limb amputations with important socio-economic impact. Peripheral vascular disease may be frequently associated in diabetes mellitus type II with its main symptom, intermittent claudication. Many studies reported the known efficacy of cilostazol in treating vascular claudication… (More)
DOI: 10.1111/iwj.12085

3 Figures and Tables


  • Presentations referencing similar topics